Pediatric Genetics Unit, Department of Pediatrics, Faculty of Medicine, Acibadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
Rare Diseases and Orphan Drugs Application and Research Center (ACURARE), Acibadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
Eur J Hum Genet. 2024 Oct;32(10):1250-1256. doi: 10.1038/s41431-023-01472-z. Epub 2023 Oct 4.
Acromesomelic dysplasia, PRKG2 type (AMDP, MIM 619636), is an extremely rare autosomal recessive skeletal dysplasia characterized by severe disproportionate short stature presenting with acromesomelia, mild metaphyseal widening of the long bones and mild spondylar dysplasia. To date, only four variants have been reported; one nonsense, one splice-site, and two frameshifts in five AMDP families. Here, we report the first missense variant and a second splice-site variant in PRKG2 in two patients with clinical and radiological features of acromesomelic dysplasia. Furthermore, functional studies of the novel missense variant, p.Val470Gly, revealed that it was unable to down-regulate FGF2-induced MAPK signaling and, thus, would be predicted to cause growth delay. Hence, this report expands the mutational spectrum in skeletal dysplasias associated with PRKG2 variants. In addition, we propose recognizable facial features with acromesomelic dysplasia, PRKG2 type.
PRKG2 型肢-体发育不良(AMDP,MIM 619636)是一种极其罕见的常染色体隐性骨骼发育不良,其特征为严重不成比例的身材矮小,表现为肢端骨发育不良、长骨轻度干骺端增宽和轻度脊柱发育不良。迄今为止,仅在五个 AMDP 家族中报道了四个变异体;一个无义突变,一个剪接位点突变,两个移码突变。在这里,我们报告了两个患者的 PRKG2 中的第一个错义变异体和第二个剪接位点变异体,这些患者具有肢-体发育不良的临床和影像学特征。此外,对新型错义变异体 p.Val470Gly 的功能研究表明,它无法下调 FGF2 诱导的 MAPK 信号,因此预计会导致生长迟缓。因此,本报告扩展了与 PRKG2 变异体相关的骨骼发育不良的突变谱。此外,我们提出了具有 PRKG2 型肢-体发育不良的可识别的面部特征。